90100048 - SYNVANTAGE

Information

• Trademark
• 90100048

• Source

• Serial Number

  90100048

• Registration Number

  7452470

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 07, 2020
  4 years ago

• Registration Date

  July 23, 2024
  5 months ago

• Transaction Date

  July 23, 2024
  5 months ago

• Status Date

  July 23, 2024
  5 months ago

• Published for Opposition Date

  May 07, 2024
  8 months ago

• Location Date

  July 22, 2024
  5 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  SNYDER, NELSON B

• Attorney Docket Number

  077752-07

  Attorney Name

  Mark A. Watkins

• Owners

  • SYNGENE INTERNATIONAL LTD

Case File Statements

• GS0051: Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical use, namely, pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergies, ehrlichiosis, ear infection, diabetes, kennel cough, upper respiratory tract infection, coccidiosis, babesiosis, ectoparasites, endoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging
• GS0011: Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequences, other than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gels, reagents, chemical standards, dyes and trace dyes for electrophoresis, other than for medical or veterinary purposes; preparative electrophoresis reagents, other than for medical or veterinary purposes
• GS0441: Drug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes
• GS0421: Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology, immunopharmaceuticals and vaccines; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; scientific and technological services, namely, scientific research, development, analysis, testing, and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; Laboratory services, namely, imaging core lab services

Case File Event Statements

• 8/11/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/9/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/4/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/10/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/10/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/10/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2021 - 3 years ago

  7 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/4/2021 - 3 years ago

  8 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/4/2021 - 3 years ago

  9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/4/2021 - 3 years ago

  10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/4/2021 - 3 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/17/2021 - 3 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/6/2021 - 3 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/6/2021 - 3 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/1/2021 - 3 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 11/30/2021 - 3 years ago

  16 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 11/30/2021 - 3 years ago

  17 - SOU EXTENSION 1 FILED Type: EXT1

• 11/30/2021 - 3 years ago

  18 - SOU EXTENSION 1 GRANTED Type: EX1G

• 12/2/2021 - 3 years ago

  19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/31/2022 - 2 years ago

  28 - 44(e) PETITION - RECEIVED Type: 44EP

• 5/31/2022 - 2 years ago

  20 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD

• 6/1/2022 - 2 years ago

  26 - SOU EXTENSION 2 FILED Type: EXT2

• 6/22/2022 - 2 years ago

  21 - ASSIGNED TO PETITION STAFF Type: APET

• 7/4/2022 - 2 years ago

  22 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 7/5/2022 - 2 years ago

  23 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 7/6/2022 - 2 years ago

  24 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 7/8/2022 - 2 years ago

  25 - PETITION GRANTED - EXTENSION REQUEST FILED Type: PGEX

• 7/8/2022 - 2 years ago

  27 - SOU EXTENSION 2 GRANTED Type: EX2G

• 7/8/2022 - 2 years ago

  29 - ASSIGNED TO PETITION STAFF Type: APET

• 7/8/2022 - 2 years ago

  30 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG

• 7/8/2022 - 2 years ago

  31 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ

• 7/8/2022 - 2 years ago

  32 - NOTICE OF REVIVAL - E-MAILED Type: NREV

• 7/9/2022 - 2 years ago

  33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/20/2022 - 2 years ago

  34 - ASSIGNED TO EXAMINER Type: DOCK

• 7/29/2022 - 2 years ago

  35 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 9/30/2022 - 2 years ago

  36 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 9/30/2022 - 2 years ago

  51 - 44(e) PETITION - RECEIVED Type: 44EP

• 10/20/2022 - 2 years ago

  37 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/20/2022 - 2 years ago

  38 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV

• 11/30/2022 - 2 years ago

  39 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 11/30/2022 - 2 years ago

  40 - SOU EXTENSION 3 FILED Type: EXT3

• 11/30/2022 - 2 years ago

  41 - SOU EXTENSION 3 GRANTED Type: EX3G

• 12/2/2022 - 2 years ago

  42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/1/2023 - a year ago

  43 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/1/2023 - a year ago

  44 - SOU EXTENSION 4 FILED Type: EXT4

• 6/1/2023 - a year ago

  45 - SOU EXTENSION 4 GRANTED Type: EX4G

• 6/3/2023 - a year ago

  46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/1/2023 - a year ago

  47 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/1/2023 - a year ago

  48 - SOU EXTENSION 5 FILED Type: EXT5

• 12/4/2023 - a year ago

  49 - SOU EXTENSION 5 GRANTED Type: EX5G

• 12/5/2023 - a year ago

  50 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/1/2024 - 9 months ago

  55 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG

• 3/5/2024 - 10 months ago

  52 - ASSIGNED TO PETITION STAFF Type: APET

• 3/6/2024 - 10 months ago

  53 - PETITION INQUIRY LETTER ISSUED Type: PILM

• 3/27/2024 - 9 months ago

  54 - TEAS RESPONSE TO PETITION INQUIRY LETTER Type: ERTI

• 4/1/2024 - 9 months ago

  56 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 4/3/2024 - 9 months ago

  57 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 4/3/2024 - 9 months ago

  58 - CASE RETURNED TO EXAMINATION Type: OTHE

• 4/3/2024 - 9 months ago

  59 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 4/17/2024 - 9 months ago

  60 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/7/2024 - 8 months ago

  61 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/7/2024 - 8 months ago

  62 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/23/2024 - 5 months ago

  63 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/23/2024 - 5 months ago

  64 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC